seed
Stage
About
Helex develops genomic medicines using proprietary lipid nanoparticle delivery and gene editing technologies to create targeted non-viral therapies for genetic kidney diseases such as Autosomal Dominant Polycystic Kidney Disease.
Explore Helex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.